Testing effectiveness (Phase 2)Study completedNCT00494585What this trial is testingCEP-701 for PH-negative MyelofibrosisWho this might be right forLeukemiaMyelofibrosis M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00724334What this trial is testingA Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With MyelofibrosisWho this might be right forMyelofibrosis Bristol-Myers Squibb 42
Early research (Phase 1)Study completedNCT06132243What this trial is testingComparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting ConditionsWho this might be right forMyelofibrosis Suzhou Zelgen Biopharmaceuticals Co.,Ltd 52
Not applicableLooking for participantsNCT02760238What this trial is testingMyeloproliferative Neoplasms (MPNs) Patient RegistryWho this might be right forPrimary MyelofibrosisPolycythemia VeraEssential Thrombocythemia+7 more University Health Network, Toronto 5,000
Testing effectiveness (Phase 2)Study completedNCT00245037What this trial is testingBusulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 147
Not applicableAvailableNCT03723148What this trial is testingIndividual Patient Compassionate Use of FedratinibWho this might be right forMyelofibrosis Celgene
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Testing effectiveness (Phase 2)Study completedNCT03136185What this trial is testingBomedemstat (IMG-7289/MK-3543) in Participants With Myelofibrosis (IMG-7289-CTP-102/MK-3543-002)Who this might be right forMyelofibrosisPost-polycythemia Vera Myelofibrosis (PPV-MF)Post-essential Thrombocythemia Myelofibrosis (PET-MF)+1 more Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) 90
Not applicableEnded earlyNCT00255684What this trial is testingFludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more University of Rochester 16
Large-scale testing (Phase 3)Not Yet RecruitingNCT07357727What this trial is testingPelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)Who this might be right forPrimary Myelofibrosis (PMF)Post-polycythemia Vera Myelofibrosis (PPV-MF)Post-essential Thrombocythemia Myelofibrosis (PET-MF) Novartis Pharmaceuticals 460
Testing effectiveness (Phase 2)Study completedNCT00569660What this trial is testingPh II Study of Azacitidine in MyelofibrosisWho this might be right forMyelofibrosis M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT04562870What this trial is testingEvaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated MyelofibrosisWho this might be right forMyelofibrosis Karyopharm Therapeutics Inc 112
Early research (Phase 1)Looking for participantsNCT05371964What this trial is testingEvaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With MyelofibrosisWho this might be right forMyelofibrosis Geron Corporation 36
Testing effectiveness (Phase 2)Ended earlyNCT01790295What this trial is testingRuxolitinib Prior to Transplant in Patients With MyelofibrosisWho this might be right forPrimary MyelofibrosisPost Polycythemia Vera MyelofibrosisPost Essential Thrombocythemia Myelofibrosis John Mascarenhas 21
Testing effectiveness (Phase 2)Study completedNCT00003406What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Cancer Treatment Centers of America 30
Early research (Phase 1)Ended earlyNCT02436135What this trial is testingStudy to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Adults Receiving Ruxolitinib as Therapy for Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis With Progressive or Relapsed DiseaseWho this might be right forMyelofibrosis Gilead Sciences 10
Not applicableStudy completedNCT01499147What this trial is testingFludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute LeukemiaChronic Myelogenous Leukemia+8 more University of Illinois at Chicago 100
Early research (Phase 1)Study completedNCT00042900What this trial is testingPyroxamide in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00069992What this trial is testingTotal-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CMLWho this might be right forChronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes Baylor College of Medicine 7
Testing effectiveness (Phase 2)Looking for participantsNCT05805605What this trial is testingAllo HSCT Using RIC and PTCy for Hematological DiseasesWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaBiphenotypic Acute Leukemia+15 more Masonic Cancer Center, University of Minnesota 56